Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
2015
Disclosure
JT, EC, DM, AAM, KLG, RAR, AOJ-L, EAO and YBM are current or former employees of Merck & Co, Inc., Whitehouse Station, NJ, USA, and may own stock and/or hold stock options in the company. HEB has received research grants as investigator and honoraria as a consultant and has served on advisory board and speaker’s bureau for Merck & Co, Inc. EAB has received research grants and honoraria from Merck & Co, Inc.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
27
References
4
Citations
NaN
KQI